Global Neurovascular Devices Market

Neurovascular Devices Market Size, Share, Growth Analysis, By Product(Embolization Devices, Clippings), By Disease Pathology(Aneurysm, Arteriovenous Malformation and Fistulas (AVM)), By Process(Neurothrombectomy Procedure, Cerebral Angiography Technique), By Therapeutic Applications(Brain Aneurysm, Stenosis), By End-Use(Hospitals, Ambulatory Surgical Centers) - Industry Forecast 2024-2031


Report ID: SQMIG35A2777 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 170 | Figures: 75

Neurovascular Devices Market Insights

Global Neurovascular Devices Market size was valued at USD 2.84 billion in 2022 and is poised to grow from USD 3.01 billion in 2023 to USD 4.53 billion by 2031, growing at a CAGR of 4.80% in the forecast period (2024-2031).

The neurovascular devices market is poised for considerable growth, propelled by several key factors including the escalating incidence of neurological disorders, continual technological advancements, and an amplified need for minimally invasive procedures. This surge is further fueled by the expansive and swiftly expanding patient populace affected by targeted ailments across major markets, driving a substantial surge in the consumption of neurovascular devices. Specifically, the heightened prevalence of acute ischemic stroke stands as a pivotal catalyst for driving market expansion over the forecast period.

Moreover, the introduction of cutting-edge products marked by technological sophistication, coupled with expedited product approval processes, is anticipated to serve as major drivers in steering the growth trajectory of this market segment.

Market snapshot - 2024-2031

Global Market Size

USD 2.84 billion

Largest Segment

Ambulatory Surgical Centers

Growth Rate

4.80% CAGR

Global Neurovascular Devices Market By End-Use ($ Bn)
Country Share for North America Region (%)
Global Neurovascular Devices Market By End-Use (%)

To get more reports on the above market click here to Buy The Report

Neurovascular Devices Market Segmental Analysis

The global Neurovascular Devices market is segmented into six segments i.e. by Product, Process, Therapeutic Applications, End-Use, Disease Pathology and Region. Based on Process, the market is segmented as, Neurothrombectomy Procedure, Cerebral Angiography Technique, Carotid Endarterectomy (CEA), Stenting, Microsurgical Clipping, Coiling, Flow Diversion, and Others. Based on Therapeutic Applications, the market is segmented as, Brain Aneurysm, Stenosis, Ischemic Strokes, and Others. Based on End-Use the market is segmented as, Hospitals, Ambulatory Surgical Centers, Clinics, Others. Based on Product the market is segmented as, Embolization Devices, Clippings, Embolic Coils, Bare Detachable Coils, Coated Detachable Coils, Coil Assist Stent, Coil Assist Balloon, Revascularization Devices, Carotid Artery Stents, Flow Diversion Stents, Thrombectomy Devices, Clot Retrieval Devices, Suction & Aspiration Devices, Snares, Embolic Protection Devices, Distal Filter Devices, Balloon Occlusion Devices, Accessory Devices, Microcatheters, and Micro-guidewires. Based on Disease Pathology the market is segmented as, Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, and Others. Based on Region the market is segmented as, North America, Europe, Asia-Pacific, LAMEA, and the Middle East and Africa.

Analysis by End-Use

The hospital segment emerged as the dominant player in the market, boasting a substantial market share of approximately 70.95% in 2022. This remarkable growth within the hospital segment is primarily attributed to the escalating number of patients grappling with neurovascular disorders, including ischemic and hemorrhagic strokes, brain aneurysms, Traumatic Brain Injury (TBI), and Arteriovenous Malformation (AVM).

The ambulatory surgical centers segment encapsulates various healthcare facilities such as emergency care centers, and long-term care centers. The projected growth of this segment is intrinsically linked to the expanding number of ASCs and the evolution of contemporary healthcare facilities. Notably, the surge in ASCs serves as a key driver for this segment's growth. For instance, data from ASC Becker indicates that the United States houses nearly 5,700 Medicare-certified ASCs, reflecting a significant upsurge in these facilities.

Analysis by Therapeutic Applications

The brain aneurysm segment is projected to exhibit the highest CAGR over the forecast period, primarily attributed to the escalating prevalence of this condition. Notably, the Brain Aneurysm Foundation reports a staggering 6.5 million individuals in the United States with unruptured brain aneurysms, and approximately 30,000 experiencing ruptures annually. This alarming prevalence underscores the critical need for advanced treatments and interventions within this segment.

Ischemic stroke emerged as the dominant segment, commanding a significant market share of approximately 57.10% in 2022, owing to various factors, notably the rising incidence of hypertension, stroke, and other neurological disorders. Highlighting the severity of this health concern, the Centers for Disease Control and Prevention (CDC) reports that globally, one in six individuals will experience a stroke during their lifetime. In the United States alone, over 795,000 people suffer from a stroke each year.

Global Neurovascular Devices Market By End-Use , 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Neurovascular Devices Market Regional Insights

North America asserted its dominance in the neurovascular devices market, commanding a substantial share of 26.44% in 2022, primarily attributed to the strong presence of key manufacturers within the region. Renowned industry players like Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit Medical Systems, Inc., among others, contribute significantly to this market stronghold through their operations in North America.

Asia Pacific is anticipated to undergo the most significant expansion with the highest CAGR during the forecast period, primarily propelled by several key factors. The region faces an escalating burden of target diseases, notably neurological disorders, exemplified by India's staggering statistics where an estimated 30 million individuals contend with various neurological conditions.

Global Neurovascular Devices Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Neurovascular Devices Market Dynamics

Drivers

Rising Popularity of Minimally Invasive Surgeries to Augment Market Growth

  • The growing popularity of minimally invasive surgeries stems from their inherent advantages, notably the diminished risks and trauma linked to these procedures. The use of smaller incisions not only reduces postoperative pain but also promotes swifter recovery times, prompting a substantial adoption of these techniques and spurring intensified research and development within this domain. Numerous prominent industry players are directing substantial investments into research and development endeavors aimed at introducing groundbreaking minimally invasive surgical instruments.

Restraints

Stringent Approval Processes is Likely to Hinder Market Growth

  • Regulatory complexities and stringent approval processes for new devices impose significant barriers, often leading to extended timelines and increased costs for product development and market entry. Additionally, the high cost associated with neurovascular procedures and devices poses a considerable challenge, limiting accessibility for certain patient demographics and healthcare systems. Limited awareness among patients and healthcare professionals about the latest technological advancements in neurovascular devices also impedes market growth.

Request Free Customization of this report to help us to meet your business objectives.

Neurovascular Devices Market Competitive Landscape

The competitive environment of the global Neurovascular Devices Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.

Top Player’s Company Profiles

  • Acandis GmbH
  • Asahi Intecc Co. Ltd.
  • Imperative Care Inc.
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Perflow Medical Ltd.
  • Rapid Medical
  • Stryker Corporation
  • Terumo Corporation
  • Medtronic
  • Johnson and Johnson Services Inc.
  • Penumbra, Inc.
  • Microvention Inc (Terumo Corporation)
  • Codman Neuro (Integra Lifesciences)

Recent Developments

  • On July 2023, RapidAI, a worldwide leader in creating Artificial Intelligence and innovation work process answers for battle perilous neurovascular, heart, and vascular illnesses, today declared $75 million in Series C subsidizing driven by Vista Credit Accomplices, an auxiliary of Vista Value Accomplices and key supporting accomplice zeroed in on the undertaking programming, information, and innovation markets. The subsidizing plans to drive stage development to help more sickness states and go-to-showcase capabilities to speed up development in new districts and item verticals.

     

  • In July 2023, Sensome SAS revealed a partnership with Asahi Intecc Co. Ltd. to foster the cutting-edge Clotild savvy guidewire. Asahi Intecc is taking on the assembling job for Sensome's savvy guidewire intended for the treatment of intense ischemic stroke.

     

  • On December 2023, BCV announced that it had secured €6 million in a Series A series of funding driven by Forepont Capital Partners, with different financial backers including NTI, MEDCO, and existing French financial backers. This Series A funding brings the aggregate sum raised since the company’s initiation to €13 million.

Neurovascular Devices Key Market Trends

  • The growing acceptance of minimally invasive surgeries owes much to their cosmetic advantages and notably reduced recovery periods, factors that are poised to significantly propel the expansion of the neurovascular devices market. Continuous strides in innovation and enhancements within surgical techniques have been pivotal in ensuring the safety of these procedures for patients. These procedures encompass a spectrum from laparoscopic and endoscopic surgeries to the advent of robot-assisted surgical techniques. The evolution towards such advanced methods heralds a promising landscape for the industry, fostering an environment conducive to further growth and development within the neurovascular devices sector.

Neurovascular Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

The global Neurovascular Devices market analysis reveals a dynamic marketplace with a number of standout trends and difficulties. The anticipated surge in the neurovascular devices market is closely linked to the escalating incidence rates of various neurological disorders across multiple countries. Conditions such as brain or cerebral aneurysms, strokes, and epilepsy, among others, are expected to be key drivers propelling market growth. As per NHS England reports, approximately 1 in 12,500 individuals in England experience a ruptured brain aneurysm annually. Additionally, the prevalence of brain aneurysms affects an estimated 3.0% of the population in the United Kingdom. Furthermore, according to the Brain Aneurysm Foundation, a staggering 6.0 million Americans grapple with the impact of brain aneurysms on an annual basis.

Report Metric Details
Market size value in 2023 USD 2.84 billion
Market size value in 2031 USD 4.53 billion
Growth Rate 4.80%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Embolization Devices, Clippings, Embolic Coils, Bare Detachable Coils, Coated Detachable Coils, Coil Assist Stent, Coil Assist Balloon, Revascularization Devices, Carotid Artery Stents, Flow Diversion Stents, Thrombectomy Devices, Clot Retrieval Devices, Suction & Aspiration Devices, Snares, Embolic Protection Devices, Distal Filter Devices, Balloon Occlusion Devices, Accessory Devices, Microcatheters, and Micro-guidewires
  • Disease Pathology
    • Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, and Others
  • Process
    • Neurothrombectomy Procedure, Cerebral Angiography Technique, Carotid Endarterectomy (CEA), Stenting, Microsurgical Clipping, Coiling, Flow Diversion, and Others
  • Therapeutic Applications
    • Brain Aneurysm, Stenosis, Ischemic Strokes, and Others
  • End-Use
    • Hospitals, Ambulatory Surgical Centers, Clinics, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Acandis GmbH
  • Asahi Intecc Co. Ltd.
  • Imperative Care Inc.
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Perflow Medical Ltd.
  • Rapid Medical
  • Stryker Corporation
  • Terumo Corporation
  • Medtronic
  • Johnson and Johnson Services Inc.
  • Penumbra, Inc.
  • Microvention Inc (Terumo Corporation)
  • Codman Neuro (Integra Lifesciences)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Neurovascular Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Neurovascular Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Neurovascular Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Neurovascular Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Neurovascular Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Neurovascular Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Neurovascular Devices Market size was valued at USD 2.84 billion in 2022 and is poised to grow from USD 3.01 billion in 2023 to USD 4.53 billion by 2031, growing at a CAGR of 4.80% in the forecast period (2024-2031).

The competitive environment of the Neurovascular Devices Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Acandis GmbH', 'Asahi Intecc Co. Ltd.', 'Imperative Care Inc.', 'Integer Holdings Corporation', 'Johnson & Johnson', 'Medtronic plc', 'MicroPort Scientific Corporation', 'Penumbra Inc.', 'Perflow Medical Ltd.', 'Rapid Medical', 'Stryker Corporation', 'Terumo Corporation', 'Medtronic', 'Johnson and Johnson Services Inc.', 'Penumbra, Inc.', 'Microvention Inc (Terumo Corporation)', 'Codman Neuro (Integra Lifesciences)'

The growing popularity of minimally invasive surgeries stems from their inherent advantages, notably the diminished risks and trauma linked to these procedures. The use of smaller incisions not only reduces postoperative pain but also promotes swifter recovery times, prompting a substantial adoption of these techniques and spurring intensified research and development within this domain. Numerous prominent industry players are directing substantial investments into research and development endeavors aimed at introducing groundbreaking minimally invasive surgical instruments.

The growing acceptance of minimally invasive surgeries owes much to their cosmetic advantages and notably reduced recovery periods, factors that are poised to significantly propel the expansion of the neurovascular devices market. Continuous strides in innovation and enhancements within surgical techniques have been pivotal in ensuring the safety of these procedures for patients. These procedures encompass a spectrum from laparoscopic and endoscopic surgeries to the advent of robot-assisted surgical techniques. The evolution towards such advanced methods heralds a promising landscape for the industry, fostering an environment conducive to further growth and development within the neurovascular devices sector.

North America asserted its dominance in the neurovascular devices market, commanding a substantial share of 26.44% in 2022, primarily attributed to the strong presence of key manufacturers within the region. Renowned industry players like Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit Medical Systems, Inc., among others, contribute significantly to this market stronghold through their operations in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Neurovascular Devices Market

Product ID: SQMIG35A2777

$5,300
BUY NOW GET FREE SAMPLE